Google
PEN Stock Analysis — PENUMBRA INC (Healthcare >> Medical Devices)
PEN FAQ
What is PEN's P/E ratio?
PENUMBRA INC (PEN) currently trades at a P/E ratio of 73.54.
What is PEN's ROE?
PENUMBRA INC reports a Return on Equity (ROE) of 11.61%.
What is PEN's dividend yield?
PENUMBRA INC offers a dividend yield of 0.00%.
What is PEN's Quality Score?
Our AI rates PEN's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy PEN?
Our AI Timing Score for PEN is 51 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does PEN belong to?
PENUMBRA INC is classified under the Healthcare >> Medical Devices sector on the NYSE exchange
PEN AI Analysis Summary
Our AI summary for PEN: PENUMBRA INC (NYSE), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 73.54, ROE of 11.61%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 51/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 321.19
Price
1.36
(0.43%)
Day Change
|
|
|---|
PEN, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
1913
|
| Magic Formula Rank by ROE |
1913
|
| Magic Formula Rank by ROIC |
1755
|
| Price | 321.19 |
| PBV / Sector |
8.54 / -101.57
|
| Earning Per Share | 4.37 |
| PE / Sector |
73.54 / 31.23
|
| PEG or PE/Growth / Sector |
-0.06 / 0.40
|
| Average 1M Daily Value |
125.11 M
GREAT
|
| Average 1W Daily Value |
116.24 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
47% |
| Ability to Make Profit |
|
60% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 08:00:19 |
| Symbol | PEN |
| Name | PENUMBRA INC |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE |
| Listed Shares | 39.33 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 12,579.37 / 20,104.97 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: One Penumbra Place, Alameda, CA, United States, 94502
Phone: 510 748 3200
Website: https://www.penumbrainc.com
Employees: 4,700
Sector: Healthcare >> Medical Devices
Description: Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
